The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
about
Current advances in biomarkers for targeted therapy in triple-negative breast cancerPhase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification.An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer.Contributions of Thyroid Hormone to Cancer Metastasis
P2860
Q28074202-275EC084-4A11-4A33-AA1B-5EEAB32EE117Q37635256-BAB2856A-E431-4F63-8A16-1C9ABF25E08DQ38647802-76083E4A-E7B6-4B48-8C32-1A0D2B7ABDA8Q40452107-0317A32B-B3BE-4345-B665-C81D6FA872B5Q48136997-1AD9EEC4-028C-476D-A95C-6D62885D4AE6Q48144964-E4CB7BC7-C085-4894-8E33-A55DBD289543Q51012619-69B2D742-DDCB-4C6D-B558-A561B2B2B2A1Q51609262-7938F0C7-5036-4485-8BE6-9E1FDAECAF43Q52660791-3C70279D-F018-48F9-8A20-C4A82BE4206FQ55008104-EDBEE1BE-836C-4FDD-BFB3-9AE9B6095957Q58717087-A7BBD517-6C8B-4838-B053-63C43C29484E
P2860
The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The three receptor tyrosine ki ...... triple-negative breast cancer.
@ast
The three receptor tyrosine ki ...... triple-negative breast cancer.
@en
type
label
The three receptor tyrosine ki ...... triple-negative breast cancer.
@ast
The three receptor tyrosine ki ...... triple-negative breast cancer.
@en
prefLabel
The three receptor tyrosine ki ...... triple-negative breast cancer.
@ast
The three receptor tyrosine ki ...... triple-negative breast cancer.
@en
P2093
P2860
P1433
P1476
The three receptor tyrosine ki ...... triple-negative breast cancer.
@en
P2093
Anna-Karin Falck
Dorthe Aamand Grabau
Kristina Aaltonen
Lisa Rydén
Mårten Fernö
Pär-Ola Bendahl
P2860
P304
P356
10.1371/JOURNAL.PONE.0102176
P407
P50
P577
2014-07-15T00:00:00Z